| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.1 |